TerrAscend (TSNDF) Other Operating Expenses (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Other Operating Expenses of -$36000.0 for Q1 2026, down 102.79% year-over-year from $1.3 million in Q1 2025, and down 100.89% quarter-over-quarter from $4.0 million in Q4 2025.
TerrAscend (TSNDF) Other Operating Expenses (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Other Operating Expenses for 6 consecutive years, with -$36000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses fell 102.79% year-over-year to -$36000.0; the TTM figure through Mar 2026 stood at $6.7 million (up 172.68% YoY), while the FY2025 annual figure was -$33000.0, down 102.77% from the prior year.
- Other Operating Expenses retreated to -$36000.0 in Q1 2026 per TSNDF's latest filing, from $4.0 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $4.7 million in Q1 2024 and bottomed at -$16.8 million in Q4 2022.
- Historically, Other Operating Expenses has averaged $143058.8 across 5 years, with a median of $1.2 million in 2024.
- Annual changes were most pronounced in 2022 — Other Operating Expenses tumbled 9363.54% — and 2025, when it soared 19104.76%.
- TerrAscend's Other Operating Expenses stood at -$16.8 million in 2022, then surged by 98.17% to -$307000.0 in 2023, then jumped by 106.84% to $21000.0 in 2024, then jumped by 19104.76% to $4.0 million in 2025, then plunged by 100.89% to -$36000.0 in 2026.
- Business Quant data shows TSNDF's Other Operating Expenses at -$36000.0 in Q1 2026, $4.0 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | TerrAscend | 187.35 Mn | 145.23 Mn | 36.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36,000.00 |
| Dec 31, 2025 | 4.03 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 4.65 Mn |
| Dec 31, 2023 | -307,000.00 |
| Sep 30, 2023 | 1.88 Mn |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | 2.36 Mn |
| Dec 31, 2022 | -16.77 Mn |
| Sep 30, 2022 | 81,000.00 |
| Jun 30, 2022 | -845,000.00 |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 181,000.00 |
| Sep 30, 2021 | -219,000.00 |
| Jun 30, 2021 | -37,000.00 |